Gapping up
In reaction to earnings/guidance:
- ASH +9.6%, ENPH +8.2%, TX +6.1%, SKX +5.6%, V +5.5%, CSGP +5.4%, WNC +4.8%, ARLP +4.7%, CHEF +4.7%, BYD +4.3%, CTOS +4.2% (also CFO to step down), CVE +4.1%, MSFT +3.9%, FCPT +3.4%, TECK +3.4%, EXAS +3.3%, ACCO +3.3%, BSX +3.3%, TMUS +3.2%, TER +3.1%, OC +3.1%, RHI +3%, BG +2.7%, TDY +2.7%, CMG +2.6%, GM +2.3%, GSK +2.1%, UMC +2.1%, MTDR +1.9%, EEFT +1.9%, SPOT +1.9%, RRC +1.7%, IQV +1.6%, NEO +1.6%, ODFL +1.5%, SF +1.4%, STM +1.3%, LYG +1.3%, GD +1.1%, MAS +1.1%, MDLZ +1%, HES +1%
Other news:
- ZNTL +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
- PCT +5% (SEC concludes investigation without further action)
- ARLP +4.7% (increases dividend; provides prelim qtrly results)
- DWAC +4.5% (currently #1 on Apple's App Store)
- LCID +3.8% (announces large EV purchase deal with Saudi Arabia)
- BG +2.6% (announces commercial partnership with CoverCress)
- AZN +1.9% (reports ENHERTU granted Breakthrough Therapy Designation in U.S. for patients with HER2 low metastatic breast cancer)
- GLPG +1.4% (names new chairman)
- HAS +1.1% (activist Alta Fox wants to replace HAS's Chairman according to Bloomberg)
Analyst comments:
- RSI +4.3% (upgraded to Overweight from Equal Weight at Wells Fargo)
- HAL +1.4% (upgraded to Buy from Hold at HSBC Securities)
- SLB +1.4% (upgraded to Buy from Hold at HSBC Securities)